VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $132,622,000 | +22.9% | 596,997 | +9.9% | 0.11% | +14.7% |
| Q1 2015 | $107,939,000 | +64.5% | 543,446 | +18.5% | 0.10% | +46.2% |
| Q4 2014 | $65,633,000 | -0.6% | 458,622 | -8.9% | 0.06% | -12.2% |
| Q3 2014 | $66,015,000 | +4.1% | 503,163 | +0.1% | 0.07% | -2.6% |
| Q2 2014 | $63,408,000 | +27.8% | 502,755 | +33.6% | 0.08% | +16.9% |
| Q1 2014 | $49,621,000 | -11.8% | 376,404 | -21.4% | 0.06% | -13.3% |
| Q4 2013 | $56,254,000 | +14.9% | 479,166 | +2.1% | 0.08% | +4.2% |
| Q3 2013 | $48,952,000 | +40.1% | 469,204 | +15.6% | 0.07% | +33.3% |
| Q2 2013 | $34,942,000 | – | 405,918 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |